ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.687,85
-0,42%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08699
0,09%
Bitcoin
70.936,77
-0,71%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Precipio Inc (PRPO)

  7. Precipio Inc (PRPO) News

PRPO

Precipio (PRPO)

Precipio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRPO
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPOPrecipio Inc
06/05/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
06/05/202423h00GlobeNewswire Inc.Precipio Secures a short-term $500K Credit FacilityNASDAQ:PRPOPrecipio Inc
25/03/202422h00GlobeNewswire Inc.Precipio Announces Year end 2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
13/02/202416h00GlobeNewswire Inc.Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoYNASDAQ:PRPOPrecipio Inc
06/02/202416h00GlobeNewswire Inc.Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for CancerNASDAQ:PRPOPrecipio Inc
23/01/202416h00GlobeNewswire Inc.Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterNASDAQ:PRPOPrecipio Inc
19/01/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRPOPrecipio Inc
17/01/202416h30GlobeNewswire Inc.Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in JapanNASDAQ:PRPOPrecipio Inc
04/01/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
04/01/202422h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
02/01/202423h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
02/01/202415h00GlobeNewswire Inc.Precipio Announces Christina Valauri joins the Board of DirectorsNASDAQ:PRPOPrecipio Inc
14/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
14/12/202322h30GlobeNewswire Inc.Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024NASDAQ:PRPOPrecipio Inc
16/11/202323h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
16/11/202323h00GlobeNewswire Inc.Precipio Announces Q3-2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
13/11/202322h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPOPrecipio Inc
31/10/202321h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
26/10/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
26/10/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
26/10/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
18/10/202315h00GlobeNewswire Inc.Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022NASDAQ:PRPOPrecipio Inc
06/10/202322h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
03/10/202316h00GlobeNewswire Inc.Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023NASDAQ:PRPOPrecipio Inc
28/09/202315h00GlobeNewswire Inc.Precipio Continues to Sign New HemeScreen™ CustomersNASDAQ:PRPOPrecipio Inc
25/09/202317h00GlobeNewswire Inc.Precipio Reduces Product Revenue Result Needed for Cash Flow BreakevenNASDAQ:PRPOPrecipio Inc
21/09/202323h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
14/09/202322h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
14/09/202322h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
 Showing the most relevant articles for your search:NASDAQ:PRPO

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
AMEX
XLF
Financial Select Sector
NYSE
JPM
JP Morgan Chase
TG
RHM
Rheinmetall
FX
EURGBP
Euro vs Sterling
USOTC
ADDYY
Adidas (QX)
NASDAQ
AMZN
Amazon.com
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
TG
DBK
Deutsche Bank
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
TG
ALV
Allianz
FX
EURUSD
Euro vs US Dollar
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten